Cargando…
Expanded Patient Access to Investigational New Devices: Review of Emergency and Nonemergency Expanded Use, Custom, and 3D-Printed Devices
U.S. Food and Drug Administration (FDA) approval of Class III medical devices can take from 3 to 7 years. Although this is shorter than times for drug approvals, patients with serious or life-threatening diseases and disorders may not have time to wait for device approval to access needed treatments...
Autor principal: | Van Norman, Gail A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115642/ https://www.ncbi.nlm.nih.gov/pubmed/30175277 http://dx.doi.org/10.1016/j.jacbts.2018.06.006 |
Ejemplares similares
-
Expanding Patient Access to Investigational New Drugs: Overview of Intermediate and Widespread Treatment Investigational New Drugs, and Emergency Authorization in Public Health Emergencies
por: Van Norman, Gail A.
Publicado: (2018) -
Expanding Patient Access to Investigational Drugs: Single Patient Investigational New Drug and the “Right to Try”
por: Van Norman, Gail A.
Publicado: (2018) -
Drugs, Devices, and the FDA: Part 2: An Overview of Approval Processes: FDA Approval of Medical Devices
por: Van Norman, Gail A.
Publicado: (2016) -
Update to Drugs, Devices, and the FDA: How Recent Legislative Changes Have Impacted Approval of New Therapies
por: Van Norman, Gail A.
Publicado: (2020) -
Drugs and Devices: Comparison of European and U.S. Approval Processes
por: Van Norman, Gail A.
Publicado: (2016)